# Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder

> **NCT00265109** · PHASE4 · COMPLETED · sponsor: **Butler Hospital** · enrollment: 17 (actual)

## Conditions studied

- Body Dysmorphic Disorder

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00265109
- **Lead sponsor:** Butler Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00265109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00265109, "Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00265109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*